Company profile: SenesTech
1.1 - Company Overview
Company description
- Provider of agricultural biotechnology life-sciences solutions for managing animal pest populations through fertility. Offers ContraPest, an EPA-registered liquid contraceptive that reduces rat fertility to control infestations, and Evolve, a soft bait that interferes with rodent reproductive mechanisms to prevent population growth.
Products and services
- Evolve: Soft-bait formulation that interferes with rodent reproductive mechanisms, targeting infestations at their source to prevent population growth
- ContraPest: EPA-registered, specifically formulated liquid contraceptive engineered to control rat pest populations by reducing their fertility
- Fertility-Based Pest Management: Agricultural-biotechnology, life-sciences service that manages animal pest populations through fertility control, focusing on reproductive inhibition as a population management method
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to SenesTech
PrimeraDx
HQ: United States
Website
- Description: Provider of multiplexed infectious disease assays and Scalable Target Amplification Routine technology for simultaneous quantitative measurement of multiple nucleic acid targets. Offers the ICEPlex system combining PCR and capillary electrophoresis, companion diagnostics, a C. difficile assay, ViraQuant for virus quantification, translational medicine research solutions, and pharma quality control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PrimeraDx company profile →
NanoMR
HQ: United States
Website
- Description: Provider of blood diagnostic devices and an immunomagnetic capture system for rapid isolation of rare cells from complex matrices at levels of 1 cell/mL or lower, enabling simultaneous targeting of multiple cell types, including bacteria and fungi from bloodstream infections, as well as specific cells such as circulating tumor and fetal cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoMR company profile →
Atera Labs
HQ: Luxembourg
Website
- Description: Provider of advanced human tissue models and tissue engineering solutions, specializing in R&D, validation, manufacturing and commercialization to deliver reliable, cost-effective, high-quality test methods for product evaluation, gradually reducing and replacing animal experimentation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Atera Labs company profile →
Cube Biotech
HQ: Germany
Website
- Description: Provider of tools and services for membrane protein research, offering cell-free protein expression, synthetic polymer and MSP nanodiscs for stabilization and purification, ultrapure detergents, protein purification products (agarose and magnetic beads), and purified membrane proteins. Germany-based, operating a two-pillared model with service and product units.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cube Biotech company profile →
Tissue Solutions
HQ: United Kingdom
Website
- Description: Provider of rapid, ethically compliant access to high-quality biospecimens via a virtual biobank offering a single point of access to diseased and normal human biomaterials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tissue Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for SenesTech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to SenesTech
2.2 - Growth funds investing in similar companies to SenesTech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for SenesTech
4.2 - Public trading comparable groups for SenesTech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →